{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Frsv-vaccines-based-on-risk-Owu1_eo5","width":444,"version":"1.0","type":"rich","title":"RSV Vaccines in Adults: A Risk-Based Approach","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/72b7228d-5feb-4764-bd24-654ccedc15fd/cco-rsv-wc-prp5896-pod647-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c90c4424-d06c-46a1-951d-ce2c21c85608\" height=\"200\" width=\"100%\" title=\"RSV Vaccines in Adults: A Risk-Based Approach\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Angela Branche, MD, share her perspective on why healthcare professionals should consider a risk-based approach—rather than age alone—to determine RSV vaccine candidacy in adults."}